A new report titled “Point-of-Care Molecular Diagnostics Market – Forecast to 2033” by Eternal Markets, the global Point-of-Care Molecular Diagnostics industry is projected to grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2033, reaching a value of USD 10,936.0 million by the end of the forecast period.
Overview
The global point-of-care (POC) molecular diagnostics market is undergoing rapid transformation driven by the necessity for quick, accurate diagnostic solutions. POC molecular diagnostics enable healthcare professionals to make informed decisions at the patient’s bedside, which improves patient outcomes and reduces reliance on centralized laboratory infrastructure. The integration of cutting-edge molecular technologies with POC testing platforms is crucial in enhancing disease management and personalized care.
Key Visions
- Estimated CAGR: Around 3.2% over the forecast period (2024-2033).
- Market Size: Projected to reach USD 10,936.0 million by 2033 from USD 8,512.0 million in 2023.
- Key Driver: The rising prevalence of infectious diseases and the growing demand for rapid diagnostic tools.
- Leading Segment: Decentralized labs segment held the largest market share by end use in 2023.
- Top Functionality: Infectious disease diagnostics segment likely to be the largest revenue contributor by 2033.
- Regional Leader: North America dominates the market due to advanced healthcare infrastructure and early adoption of new technologies.
Key Market Drivers
Several pivotal factors are propelling the POC molecular diagnostics market forward:
Rising Prevalence of Infectious Diseases: The global increase in infectious diseases such as HIV, influenza, and tuberculosis is significantly driving the demand for rapid and accurate POC diagnostics.
Technological Advancements: Innovations in molecular diagnostics technologies, including PCR and isothermal nucleic acid amplification, are enhancing test accuracy and speed, thus driving market growth.
Shift Towards Decentralized Healthcare: The growing trend towards decentralized healthcare settings necessitates immediate diagnostic results at the point of care, boosting market demand.
Government Initiatives and Funding: Increasing government funding and supportive policies for the development and deployment of POC diagnostics are accelerating market growth.
Growing Adoption in Emerging Markets: Expanding healthcare infrastructure and rising awareness in emerging economies are contributing to the adoption of POC molecular diagnostics.
Restraining Factors
Regulatory Challenges: Strict regulatory requirements can delay product approvals and market entry.
High Costs: Advanced POC diagnostic devices and assays can be expensive, limiting adoption in low-resource settings.
Limited Awareness and Accessibility: In some regions, lack of awareness and accessibility to advanced diagnostics hampers market growth.
Future Scope
The POC molecular diagnostics market is expected to grow significantly in the future, driven by:
Integration with Digital Health: Improved connectivity with digital health platforms for better data management and remote diagnostics.
Development of Multiplex Assays: Assays capable of detecting multiple pathogens simultaneously, enhancing diagnostic capabilities.
Expansion into Oncology and Genetic Testing: Increasing application in cancer diagnostics and genetic disease screening.
Increased Use in Home Care Settings: Development of user-friendly, portable devices for use in home care settings.
Major Strategies adopted by key market players.
- Agreements, Collaborations, and Partnerships: 24%
- Acquisitions: 20%
- New Product Launch: _%
- Other Developments: _%
Geographical Analysis
North America: Dominates the market due to advanced healthcare infrastructure and early adoption of new technologies.
Europe: Significant growth driven by strong government support and increasing R&D investments.
Asia-Pacific: High growth potential due to expanding healthcare access and rising prevalence of infectious diseases.
Recent Developments
2023: Introduction of new multiplex POC assays for infectious diseases by Abbott Laboratories.
2022: Major merger of Qiagen N.V. with Thermo Fisher Scientific Inc. to expand their product portfolios and market reach.
2021: Strategic partnership between Becton, Dickinson and Company and bioMérieux SA for technological advancements in POC diagnostics.
2020: Launch of innovative POC diagnostic platforms by Cepheid (Danaher Corporation), enhancing test accuracy and speed.
Scope of the Report:
Global Point-of-Care Molecular Diagnostics Market, By Location
Global Point-of-Care Molecular Diagnostics Market, By Application
- Infectious Diseases
-
HIV POC
-
Clostridium difficile POC
-
HBV POC
-
Pneumonia or Streptococcus associated infections
-
Respiratory syncytial virus (RSV) POC
-
HPV POC
-
Influenza/Flu POC
-
HCV POC
-
MRSA POC
-
TB and drug-resistant TB POC
-
HSV POC
-
Other Infectious Diseases
-
Oncology
-
Hematology
-
Prenatal Testing
-
Endocrinology
-
Other Applications
Global Point-of-Care Molecular Diagnostics Market, By Technology
- PCR-based
- Genetic Sequencing-based
- Hybridization-based
- Microarray-based
Global Point-of-Care Molecular Diagnostics Market, By End Use
- Decentralized Labs
- Hospitals
- Home-care
- Others
Global Point-of-Care Molecular Diagnostics Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
● F. Hoffmann-La Roche AG
● Abbott
● QIAGEN
● Bayer AG
● Nova Biomedical
● Danaher
● Nipro Diagnostics
● Bio-Rad Laboratories, Inc.
● Agilent Technologies, Inc.
● bioMérieux
● OraSure Technologies
● Abaxis
● Other key players
*The report scope shall be customized as per the requirements
Chapter 1 Global Point-of-Care Molecular Diagnostics Market Overview
1.1 Introduction
1.2 Drivers for Point-of-Care Molecular Diagnostics Market
1.3 Restraints for Point-of-Care Molecular Diagnostics Market
1.4 Opportunities for Point-of-Care Molecular Diagnostics Market
1.5 Trends for Point-of-Care Molecular Diagnostics Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Point-of-Care Molecular Diagnostics Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 F. Hoffmann-La Roche AG
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2023
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Abbott
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2023
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 QIAGEN
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2023
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Bayer AG
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2023
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Nova Biomedical
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2023
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Danaher
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2023
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Nipro Diagnostics
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2023
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Bio-Rad Laboratories, Inc.
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2023
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Agilent Technologies, Inc.
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2023
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 bioMérieux
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2023
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Point-of-Care Molecular Diagnostics Market Overview
3.1 Global Point-of-Care Molecular Diagnostics Market Outlook (2018-2033)
3.1.1 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2018-2024)
3.1.2 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2025-2033)
3.2 Global Point-of-Care Molecular Diagnostics Market by Region
3.2.1 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2033)
3.2.2 Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
3.3 Global Point-of-Care Molecular Diagnostics Market by Location
3.3.1 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2033)
3.3.2 Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Location, 2024–2033
3.3.3 Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
3.4 Global Point-of-Care Molecular Diagnostics Market by Application
3.4.1 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2033)
3.4.2 Global Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Application, 2024–2033
3.5 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Region
3.5.1 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2024)
3.5.2 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2025-2033)
3.6 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Location
3.6.1 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2024)
3.6.2 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2025-2033)
3.7 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Application
3.7.1 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2024)
3.7.2 Global Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2025-2033)
3.8 Global Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate Comparison 2019–2033
3.8.1 Global Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Region
3.8.2 Global Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Location
3.8.3 Global Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Application
3.9 Global Point-of-Care Molecular Diagnostics Market Share Comparison 2018–2033
3.9.1 Global Point-of-Care Molecular Diagnostics Market Share by Region
3.9.2 Global Point-of-Care Molecular Diagnostics Market Share by Location
3.9.3 Global Point-of-Care Molecular Diagnostics Market Share by Application
Chapter 4 North America Point-of-Care Molecular Diagnostics Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Point-of-Care Molecular Diagnostics Market Outlook (2018-2033)
4.2.1 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2018-2024)
4.2.2 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2025-2033)
4.3 North America Point-of-Care Molecular Diagnostics Market by Region
4.3.1 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2033)
4.3.2 North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
4.4 North America Point-of-Care Molecular Diagnostics Market by Location
4.4.1 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2033)
4.4.2 North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Location, 2024–2033
4.4.3 North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
4.5 North America Point-of-Care Molecular Diagnostics Market by Application
4.5.1 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2033)
4.5.2 North America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Application, 2024–2033
4.6 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Region
4.6.1 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2024)
4.6.2 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2025-2033)
4.7 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Location
4.7.1 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2024)
4.7.2 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2025-2033)
4.8 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Application
4.8.1 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2024)
4.8.2 North America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2025-2033)
4.9 North America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate Comparison 2019–2033
4.9.1 North America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Region
4.9.2 North America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Location
4.9.3 North America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Application
4.1 North America Point-of-Care Molecular Diagnostics Market Share Comparison 2018–2033
4.10.1 North America Point-of-Care Molecular Diagnostics Market Share by Region
4.10.2 North America Point-of-Care Molecular Diagnostics Market Share by Location
4.10.3 North America Point-of-Care Molecular Diagnostics Market Share by Application
Chapter 5 Europe Point-of-Care Molecular Diagnostics Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Point-of-Care Molecular Diagnostics Market Outlook (2018-2033)
5.2.1 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2018-2024)
5.2.2 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2025-2033)
5.3 Europe Point-of-Care Molecular Diagnostics Market by Region
5.3.1 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2033)
5.3.2 Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
5.4 Europe Point-of-Care Molecular Diagnostics Market by Location
5.4.1 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2033)
5.4.2 Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Location, 2024–2033
5.4.3 Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
5.5 Europe Point-of-Care Molecular Diagnostics Market by Application
5.5.1 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2033)
5.5.2 Europe Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Application, 2024–2033
5.6 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Region
5.6.1 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2024)
5.6.2 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2025-2033)
5.7 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Location
5.7.1 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2024)
5.7.2 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2025-2033)
5.8 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Application
5.8.1 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2024)
5.8.2 Europe Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2025-2033)
5.9 Europe Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate Comparison 2019–2033
5.9.1 Europe Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Region
5.9.2 Europe Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Location
5.9.3 Europe Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Application
5.1 Europe Point-of-Care Molecular Diagnostics Market Share Comparison 2018–2033
5.10.1 Europe Point-of-Care Molecular Diagnostics Market Share by Region
5.10.2 Europe Point-of-Care Molecular Diagnostics Market Share by Location
5.10.3 Europe Point-of-Care Molecular Diagnostics Market Share by Application
Chapter 6 Asia Pacific Point-of-Care Molecular Diagnostics Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Outlook (2018-2033)
6.2.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2018-2024)
6.2.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2025-2033)
6.3 Asia Pacific Point-of-Care Molecular Diagnostics Market by Region
6.3.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2033)
6.3.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
6.4 Asia Pacific Point-of-Care Molecular Diagnostics Market by Location
6.4.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2033)
6.4.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Location, 2024–2033
6.4.3 Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
6.5 Asia Pacific Point-of-Care Molecular Diagnostics Market by Application
6.5.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2033)
6.5.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Application, 2024–2033
6.6 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Region
6.6.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2024)
6.6.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2025-2033)
6.7 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Location
6.7.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2024)
6.7.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2025-2033)
6.8 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Application
6.8.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2024)
6.8.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2025-2033)
6.9 Asia Pacific Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate Comparison 2019–2033
6.9.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Location
6.9.3 Asia Pacific Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Application
6.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Share Comparison 2018–2033
6.10.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Share by Region
6.10.2 Asia Pacific Point-of-Care Molecular Diagnostics Market Share by Location
6.10.3 Asia Pacific Point-of-Care Molecular Diagnostics Market Share by Application
Chapter 7 South America Point-of-Care Molecular Diagnostics Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Point-of-Care Molecular Diagnostics Market Outlook (2018-2033)
7.2.1 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2018-2024)
7.2.2 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2025-2033)
7.3 South America Point-of-Care Molecular Diagnostics Market by Region
7.3.1 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2033)
7.3.2 South America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
7.4 South America Point-of-Care Molecular Diagnostics Market by Location
7.4.1 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2033)
7.4.2 South America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Location, 2024–2033
7.4.3 South America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
7.5 South America Point-of-Care Molecular Diagnostics Market by Application
7.5.1 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2033)
7.5.2 South America Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Application, 2024–2033
7.6 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Region
7.6.1 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2024)
7.6.2 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2025-2033)
7.7 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Location
7.7.1 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2024)
7.7.2 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2025-2033)
7.8 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Application
7.8.1 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2024)
7.8.2 South America Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2025-2033)
7.9 South America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate Comparison 2019–2033
7.9.1 South America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Region
7.9.2 South America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Location
7.9.3 South America Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Application
7.1 South America Point-of-Care Molecular Diagnostics Market Share Comparison 2018–2033
7.10.1 South America Point-of-Care Molecular Diagnostics Market Share by Region
7.10.2 South America Point-of-Care Molecular Diagnostics Market Share by Location
7.10.3 South America Point-of-Care Molecular Diagnostics Market Share by Application
Chapter 8 Middle East and Africa Point-of-Care Molecular Diagnostics Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Outlook (2018-2033)
8.2.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2018-2024)
8.2.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) (2025-2033)
8.3 Middle East and Africa Point-of-Care Molecular Diagnostics Market by Region
8.3.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2033)
8.3.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
8.4 Middle East and Africa Point-of-Care Molecular Diagnostics Market by Location
8.4.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2033)
8.4.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Location, 2024–2033
8.4.3 Middle East and Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Region, 2024–2033
8.5 Middle East and Africa Point-of-Care Molecular Diagnostics Market by Application
8.5.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2033)
8.5.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Attractiveness Analysis by Application, 2024–2033
8.6 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Region
8.6.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2018-2024)
8.6.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Region (2025-2033)
8.7 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Location
8.7.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2018-2024)
8.7.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Location (2025-2033)
8.8 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) by Application
8.8.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2018-2024)
8.8.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Value (US$ Mn) Comparison by Application (2025-2033)
8.9 Middle East and Africa Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate Comparison 2019–2033
8.9.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Location
8.9.3 Middle East and Africa Point-of-Care Molecular Diagnostics Market Y-o-Y Growth Rate by Application
8.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Share Comparison 2018–2033
8.10.1 Middle East and Africa Point-of-Care Molecular Diagnostics Market Share by Region
8.10.2 Middle East and Africa Point-of-Care Molecular Diagnostics Market Share by Location
8.10.3 Middle East and Africa Point-of-Care Molecular Diagnostics Market Share by Application
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
